A large panel of CD8+ T cell clones generated from peripheral blood lymphocytes (PBL) of healthy donors or human immunodeficiency virus (HIV)-infected individuals were assessed for both cytokine secretion profile and CD30 expression and release. The great majority of CD8+ T cell clones generated from healthy individuals showed the ability to produce interferon gamma (IFN-gamma), but not interleukin 4 (IL-4), and none of them either expressed membrane CD30 or released substantial amounts of soluble CD30 (sCD30) in their supernatant. In contrast, high numbers of CD8+ T cell clones generated from HIV-infected individuals, which produced IL-4 (and IL-5) in addition to IFN-gamma or IL-4 (and IL-5) alone, expressed membrane CD30 and released detectable amounts of sCD30 in their supernatants. Indeed, CD30 expression appeared to be positively correlated with the ability of CD8+ T cell clones to produce IL-4 and IL-5 and inversely correlated with their ability to produce IFN-gamma, whereas no correlation between CD30 expression and production of IL-10 was observed. These data suggest that CD30 is a marker for CD8+ T cells that have switched to the production of type 2 helper cytokines.
Skip Nav Destination
Article navigation
1 December 1994
Article|
December 01 1994
CD30 expression by CD8+ T cells producing type 2 helper cytokines. Evidence for large numbers of CD8+CD30+ T cell clones in human immunodeficiency virus infection.
R Manetti,
R Manetti
Division of Clinical Immunology and Allergy, University of Florence, Italy.
Search for other works by this author on:
F Annunziato,
F Annunziato
Division of Clinical Immunology and Allergy, University of Florence, Italy.
Search for other works by this author on:
R Biagiotti,
R Biagiotti
Division of Clinical Immunology and Allergy, University of Florence, Italy.
Search for other works by this author on:
M G Giudizi,
M G Giudizi
Division of Clinical Immunology and Allergy, University of Florence, Italy.
Search for other works by this author on:
M P Piccinni,
M P Piccinni
Division of Clinical Immunology and Allergy, University of Florence, Italy.
Search for other works by this author on:
L Giannarini,
L Giannarini
Division of Clinical Immunology and Allergy, University of Florence, Italy.
Search for other works by this author on:
S Sampognaro,
S Sampognaro
Division of Clinical Immunology and Allergy, University of Florence, Italy.
Search for other works by this author on:
P Parronchi,
P Parronchi
Division of Clinical Immunology and Allergy, University of Florence, Italy.
Search for other works by this author on:
F Vinante,
F Vinante
Division of Clinical Immunology and Allergy, University of Florence, Italy.
Search for other works by this author on:
G Pizzolo,
G Pizzolo
Division of Clinical Immunology and Allergy, University of Florence, Italy.
Search for other works by this author on:
E Maggi,
E Maggi
Division of Clinical Immunology and Allergy, University of Florence, Italy.
Search for other works by this author on:
S Romagnani
S Romagnani
Division of Clinical Immunology and Allergy, University of Florence, Italy.
Search for other works by this author on:
R Manetti
Division of Clinical Immunology and Allergy, University of Florence, Italy.
F Annunziato
Division of Clinical Immunology and Allergy, University of Florence, Italy.
R Biagiotti
Division of Clinical Immunology and Allergy, University of Florence, Italy.
M G Giudizi
Division of Clinical Immunology and Allergy, University of Florence, Italy.
M P Piccinni
Division of Clinical Immunology and Allergy, University of Florence, Italy.
L Giannarini
Division of Clinical Immunology and Allergy, University of Florence, Italy.
S Sampognaro
Division of Clinical Immunology and Allergy, University of Florence, Italy.
P Parronchi
Division of Clinical Immunology and Allergy, University of Florence, Italy.
F Vinante
Division of Clinical Immunology and Allergy, University of Florence, Italy.
G Pizzolo
Division of Clinical Immunology and Allergy, University of Florence, Italy.
E Maggi
Division of Clinical Immunology and Allergy, University of Florence, Italy.
S Romagnani
Division of Clinical Immunology and Allergy, University of Florence, Italy.
Online ISSN: 1540-9538
Print ISSN: 0022-1007
J Exp Med (1994) 180 (6): 2407–2411.
Citation
R Manetti, F Annunziato, R Biagiotti, M G Giudizi, M P Piccinni, L Giannarini, S Sampognaro, P Parronchi, F Vinante, G Pizzolo, E Maggi, S Romagnani; CD30 expression by CD8+ T cells producing type 2 helper cytokines. Evidence for large numbers of CD8+CD30+ T cell clones in human immunodeficiency virus infection.. J Exp Med 1 December 1994; 180 (6): 2407–2411. doi: https://doi.org/10.1084/jem.180.6.2407
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement